- Home
- OFLX vs CERS Comparison
OFLX vs CERS Comparison
Compare OFLX & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- CERS
- Stock Information
- Founded
- OFLX 1975
- CERS 1991
- Country
- OFLX United States
- CERS United States
- Employees
- OFLX N/A
- CERS N/A
- Industry
- OFLX Industrial Specialties
- CERS EDP Services
- Sector
- OFLX Industrials
- CERS Technology
- Exchange
- OFLX Nasdaq
- CERS Nasdaq
- Market Cap
- OFLX 374.3M
- CERS 347.3M
- IPO Year
- OFLX 2005
- CERS 1997
- Fundamental
- Price
- OFLX $30.83
- CERS $1.29
- Analyst Decision
- OFLX
- CERS Strong Buy
- Analyst Count
- OFLX 0
- CERS 2
- Target Price
- OFLX N/A
- CERS $3.50
- AVG Volume (30 Days)
- OFLX 20.7K
- CERS 991.7K
- Earning Date
- OFLX 04-30-2025
- CERS 05-01-2025
- Dividend Yield
- OFLX 4.52%
- CERS N/A
- EPS Growth
- OFLX N/A
- CERS N/A
- EPS
- OFLX 1.72
- CERS N/A
- Revenue
- OFLX $99,795,000.00
- CERS $185,144,000.00
- Revenue This Year
- OFLX N/A
- CERS $25.57
- Revenue Next Year
- OFLX N/A
- CERS $10.54
- P/E Ratio
- OFLX $17.92
- CERS N/A
- Revenue Growth
- OFLX N/A
- CERS 13.06
- 52 Week Low
- OFLX $28.12
- CERS $1.12
- 52 Week High
- OFLX $67.56
- CERS $2.54
- Technical
- Relative Strength Index (RSI)
- OFLX 45.29
- CERS 45.00
- Support Level
- OFLX $29.72
- CERS $1.22
- Resistance Level
- OFLX $31.38
- CERS $1.38
- Average True Range (ATR)
- OFLX 1.28
- CERS 0.07
- MACD
- OFLX 0.30
- CERS 0.00
- Stochastic Oscillator
- OFLX 68.61
- CERS 26.92
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.